Literature DB >> 891584

A multicentre study of rauwolfia derivates and breast cancer.

L J Christopher, J Crooks, J F Davidson, Z G Erskine, S C Gallon, D C Moir, R D Weir.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 891584     DOI: 10.1007/bf00562930

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  6 in total

1.  Reserpine and breast cancer in a retirement community.

Authors:  T M Mack; B E Henderson; V R Gerkins; M Arthur; J Baptista; M C Pike
Journal:  N Engl J Med       Date:  1975-06-26       Impact factor: 91.245

2.  Reserpine use in relation to breast cancer.

Authors:  O P Heinonen; S Shapiro; L Tuominen; M I Turunen
Journal:  Lancet       Date:  1974-09-21       Impact factor: 79.321

3.  Retrospective study of the association between use of rauwolfia derivatives and breast cancer in English women.

Authors:  B Armstrong; N Stevens; R Doll
Journal:  Lancet       Date:  1974-09-21       Impact factor: 79.321

4.  Rauwolfia derivatives and breast cancer. A case/control study in Olmsted County, Minnesota.

Authors:  W M O'Fallon; D R Labarthe; L T Kurland
Journal:  Lancet       Date:  1975-08-16       Impact factor: 79.321

5.  Matched-pairs study of reserpine use and breast cancer.

Authors:  E M Laska; C Siegel; M Meisner; S Fischer; J Wanderling
Journal:  Lancet       Date:  1975-08-16       Impact factor: 79.321

6.  Rauwolfia derivatives and breast cancer in hypertensive women.

Authors:  B Armstrong; D Skegg; G White; R Doll
Journal:  Lancet       Date:  1976-07-03       Impact factor: 79.321

  6 in total
  4 in total

Review 1.  [Reserpine-diuretic combinations in therapy of arterial hypertension. Current considerations].

Authors:  M Siepmann; W Kirch
Journal:  Med Klin (Munich)       Date:  1998-12-15

Review 2.  Reserpine: a relic from the past or a neglected drug of the present for achieving cost containment in treating hypertension?

Authors:  G J Magarian
Journal:  J Gen Intern Med       Date:  1991 Nov-Dec       Impact factor: 5.128

3.  Drug epidemiology and clinical pharmacology: their contribution to patient care.

Authors:  J Crooks
Journal:  Br J Clin Pharmacol       Date:  1983-10       Impact factor: 4.335

4.  Getting to goal blood pressure: why reserpine deserves a second look.

Authors:  Joshua Barzilay; Richard Grimm; William Cushman; Alain G Bertoni; Jan Basile
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-08       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.